EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses

Janet A Grimes iD, Jennifer M Schmiedt

American Journal of Veterinary Research · 2026

DOI: 10.2460/ajvr.25.07.0258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Janet A Grimes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA. Hauptthemen laut MEDLINE: Hemangiosarcoma, Dog Diseases, Splenic Neoplasms, MicroRNAs. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify a panel of circulating microRNAs (miRNAs) that accurately discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses.

Methods

Serum samples from 10 dogs with hemangiosarcoma and 20 dogs with noncancerous splenic masses were included. Quantitative reverse transcription PCR was performed for 8 candidate miRNAs (miRNA [miR]-126-5p, miR-150-5p, miR-203a-3p, miR-214-3p, miR-452-5p, miR-494-3p, miR-497-5p, and miR-543) and 2 reference genes (miR-16-5p and miR-93-5p). Multivariable logistic regression was performed to identify a panel of miRNAs diagnostic for hemangiosarcoma.

Results

The combination of miR-126-5p, miR-150-5p, miR-452-5p, and miR-543 had an area under the curve of 0.930, a sensitivity of 80%, a specificity of 90%, and a Youden J of 0.700 for discriminating dogs with hemangiosarcoma from those with noncancerous splenic masses.

Conclusions

This panel of 4 miRNAs can be used to discriminate noncancerous splenic masses from hemangiosarcoma in dogs with splenic masses. Clinical Relevance The ability to determine the nature of a splenic mass prior to surgery will provide veterinarians and their clients with important knowledge prior to surgery. If a mass is not hemangiosarcoma, owners may be more likely to proceed with surgery rather than euthanasia. Knowing that a mass is hemangiosarcoma will provide information to owners on the need for adjuvant therapy following surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemangiosarcomaDog DiseasesSplenic NeoplasmsMicroRNAsCirculating MicroRNAAnimalsDogsFemaleMaleBiomarkers, Tumor

Stichwörter der Autor:innen

caninediagnostichemangiosarcomamicroRNAspleen

Substanzen

MicroRNAsCirculating MicroRNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA.
  • Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA.

ORCID-Profile: Janet A Grimes

Zitieren

APA

Grimes, J. A., & Schmiedt, J. M. (2026). A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.07.0258

Vancouver

Grimes JA, Schmiedt JM. A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.25.07.0258

BibTeX
@article{Grimes2026,
  author = {Grimes, Janet A and Schmiedt, Jennifer M},
  title = {A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses},
  journal = {American Journal of Veterinary Research},
  year = {2026},
  doi = {10.2460/ajvr.25.07.0258}
}
Kostenlos starten →